Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
6 hedge funds and large institutions have $7.26K invested in Altamira Therapeutics Ltd in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
79% less capital invested
Capital invested by funds: $34.5K → $7.26K (-$27.3K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$8.85K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$6.61K |
| 2 |
Morgan Stanley
New York
|
-$4.25K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$3.63K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citigroup
New York
| $3.94K | +$8.85K | +154 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $1.96K | -$6.61K | -115 | -60% |
|
|
3
Morgan Stanley
New York
| $1.31K | -$4.25K | -74 | -59% |
|
4
Wells Fargo
San Francisco,
California
| $32 | – | – | – |
|
5
Osaic Holdings
Scottsdale,
Arizona
| $19 | – | – | – |
|
|
SCA
6
Stonebridge Capital Advisors
St Paul,
Minnesota
| $6 | – | – | – |
|
|
7
Group One Trading
Chicago,
Illinois
| – | -$3.63K | -37 | Closed |
|
CYTO Hedge Fund Activity: Q1 2023 in Review
6 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q1 2023, worth a combined $7.26K — down 79% from $34.5K a quarter earlier.
Fund positioning in CYTO was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Citigroup, opening a new position worth an estimated $8.85K. The largest seller was UBS Group, cutting an estimated $6.61K.
- 6 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $7.26K of Altamira Therapeutics Ltd stock for Q1 2023, down 79% quarter-over-quarter.
- 1 fund opened new Altamira Therapeutics Ltd positions in Q1 2023 and 1 closed out, a net change of 0 holders.
- The largest Altamira Therapeutics Ltd buyer in Q1 2023 was Citigroup, an estimated $8.85K added.
- The largest Altamira Therapeutics Ltd seller in Q1 2023 was UBS Group, an estimated $6.61K sold.
Based on aggregated 13F filings for Q1 2023.